Search
East Asia Pharmaceutical Secures Drug Registration for Levofloxacin Tablets
2 day ago /
Read about 0 minute
Author：小编
East Asia Pharmaceutical has recently secured the drug registration certificate for Levofloxacin Tablets, approved and issued by the National Medical Products Administration. This milestone signifies the approval of the company's maiden pharmaceutical preparation product, propelling forward its integrated development strategy encompassing active pharmaceutical ingredients and pharmaceutical preparations. The acquisition of this certificate not only diversifies the company's product portfolio but is also anticipated to bolster its market competitiveness. Nevertheless, amidst the uncertainties posed by policy shifts and market fluctuations within the pharmaceutical industry, the company must navigate these challenges with prudence.
-
C114 Communication Network -
Communication Home
7 X 24 Track global technological trends
